Firm News

NGE Represents RecoveryOne in $33 Million Series C Preferred Stock Round

NGE served as counsel to RecoveryOne in its $33 million Series C funding round, led by new investors Cobalt Ventures and TELUS Ventures, along with existing investors 7wireVentures Fund & Cigna Ventures.  RecoveryOne is a leading innovator in evidence-based solutions that personalize and improve the path to recovery from musculoskeletal conditions.  The NGE team was led by Corporate & Securities partners Josh Klein and Michael Gray with assistance from Jonathan Levine, Joe Paolucci, Elaine Taussig and Rebecca Benner.